These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26910383)

  • 21. Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease.
    Martín-Varillas JL; Calvo-Río V; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Garfella MH; Pascual EV; Martínez-Costa L; Sellas-Fernández A; Cordero-Coma M; Díaz-Llopis M; Gallego R; Salom D; Ortego N; García-Serrano JL; Callejas-Rubio JL; Herreras JM; García-Aparicio Á; Maíz O; Blanco A; Torre I; Díaz-Valle D; Pato E; Aurrecoechea E; Caracuel MA; Gamero F; Minguez E; Carrasco-Cubero C; Olive A; Vázquez J; Ruiz-Moreno O; Manero J; Muñoz-Fernández S; Martinez MG; Rubio-Romero E; Toyos-Sáenz de Miera FJ; López Longo FJ; Nolla JM; Revenga M; González-Vela C; Loricera J; Atienza-Mateo B; Demetrio-Pablo R; Hernández JL; González-Gay MA; Blanco R
    Ophthalmology; 2018 Sep; 125(9):1444-1451. PubMed ID: 29602570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
    Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Efficacy of Pegylated Interferon Alpha-2b in Behçet's Uveitis: A Small Case Series.
    Celiker H; Kazokoglu H; Direskeneli H
    Ocul Immunol Inflamm; 2019; 27(1):15-22. PubMed ID: 28700247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of interferon alfa-2r in the treatment of autoimmune uveitis (primary or associated with Behçet's disease)].
    Sánchez Román J; Pulido Aguilera MC; Castillo Palma MJ; Ocaña Medina C; Toral Peña A; López-Checa F; Wichmann I
    Rev Clin Esp; 1996 May; 196(5):293-8. PubMed ID: 8768028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical observation of 85 patients with Behçet's uveitis treated with immunosuppressive agents combined with steroids].
    Zhao M; Wang H; Jiao X; Wei WB
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):202-6. PubMed ID: 23866699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease.
    Wechsler B; Bodaghi B; Huong DL; Fardeau C; Amoura Z; Cassoux N; Piette JC; LeHoang P
    Ocul Immunol Inflamm; 2000 Dec; 8(4):293-301. PubMed ID: 11262659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ocular manifestation of Behçet disease (study of 50 patients consulting in dermatology department)].
    Janati K; EL Omari K; Benchiki H; Hamdani M; Lakhdar H
    Rev Med Interne; 2005 Oct; 26(10):771-6. PubMed ID: 16169129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uveitis associated with pediatric behçet disease in the american midwest.
    Kesen MR; Goldstein DA; Tessler HH
    Am J Ophthalmol; 2008 Dec; 146(6):819-27.e2. PubMed ID: 18672222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease.
    Yamada Y; Sugita S; Tanaka H; Kamoi K; Kawaguchi T; Mochizuki M
    Br J Ophthalmol; 2010 Mar; 94(3):284-8. PubMed ID: 19692382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value and complications of immunosuppressive therapy in uveitis of Behcet's disease or of other etiology. Apropos of 40 cases].
    Niessen F; Campinchi R; Bloch-Michel E
    J Fr Ophtalmol; 1982; 5(6-7):407-16. PubMed ID: 7130629
    [No Abstract]   [Full Text] [Related]  

  • 31. Azathioprine in severe uveitis of Behçet's disease.
    Saadoun D; Wechsler B; Terrada C; Hajage D; Le Thi Huong D; Resche-Rigon M; Cassoux N; Le Hoang P; Amoura Z; Bodaghi B; Cacoub P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1733-8. PubMed ID: 20665749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Light on the horizont: biologicals in Behçet uveitis.
    Hazirolan D; Stübiger N; Pleyer U
    Acta Ophthalmol; 2013 Jun; 91(4):297-306. PubMed ID: 22520021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon alfa combined with azathioprine for the uveitis of Behçet's disease: an open study.
    Hamuryudan V; Ozyazgan Y; Fresko Y; Mat C; Yurdakul S; Yazici H
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):928-30. PubMed ID: 12455182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood-onset uveitis in Behçet disease:a descriptive study of 36 cases.
    Tugal-Tutkun I; Urgancioglu M
    Am J Ophthalmol; 2003 Dec; 136(6):1114-9. PubMed ID: 14644223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential of Pegylated Interferon Alpha-2a in Behçet Uveitis: A Report of Five Cases.
    Bielefeld P; Devilliers H; Deschasse C; Saadoun D; Sève P; Muselier A; Creuzot-Garcher C; Besancenot JF; Bron AM
    Ocul Immunol Inflamm; 2016 Oct; 24(5):599-602. PubMed ID: 25760915
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.
    Takeuchi M; Kezuka T; Sugita S; Keino H; Namba K; Kaburaki T; Maruyama K; Nakai K; Hijioka K; Shibuya E; Komae K; Hori J; Ohguro N; Sonoda KH; Mizuki N; Okada AA; Ishibashi T; Goto H; Mochizuki M
    Ophthalmology; 2014 Oct; 121(10):1877-84. PubMed ID: 24950593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uveitis in Behçet disease: an analysis of 880 patients.
    Tugal-Tutkun I; Onal S; Altan-Yaycioglu R; Huseyin Altunbas H; Urgancioglu M
    Am J Ophthalmol; 2004 Sep; 138(3):373-80. PubMed ID: 15364218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy.
    Eser Ozturk H; Oray M; Tugal-Tutkun I
    Ocul Immunol Inflamm; 2018; 26(7):1005-1014. PubMed ID: 29020500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uveitis in Behçet disease - an update.
    Tugal-Tutkun I
    Curr Opin Rheumatol; 2023 Jan; 35(1):17-24. PubMed ID: 36255985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical course and outcome of uveitis in children.
    Friling R; Kramer M; Snir M; Axer-Siegel R; Weinberger D; Mukamel M
    J AAPOS; 2005 Aug; 9(4):379-82. PubMed ID: 16102490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.